What happens when a promising therapy falls short? Medscape spoke with Jeffrey Cummings, MD, who led the EVOKE trials of the GLP-1 semaglutide for AD, about what the results mean — and what comes next ...

While the research does not point to a direct, causal link, it hints that activities like reading, writing and playing games ...

The new generation of Alzheimer's disease drugs—the first proven to change the course of the disease—typically extend ...

The shingles vaccine is really good at preventing shingles. But new research suggests it may also be really good at preventing other ailments, like dementia and cardiovascular disease.

A recent study examines why Alzheimer’s presents and progresses differently in individuals using advanced biological analysis ...

Alzheimer’s disease and related dementias were less likely among adults who completed cognitive speed training with booster sessions, according to data published in Alzheimer’s & Dementia: ...

Dementia is a group of brain disorders that cause a decline in cognitive functions like memory and thinking. While some cognitive decline is a natural part of aging, dementia is an extreme version ...

A recent study shows that accessible blood tests can accurately identify Alzheimer’s disease. When combined with standard cognitive assessments, these tools offer a reliable diagnostic approach for ...

Advanced practice providers expand access by conducting initial consults, ordering diagnostic workups, explaining anti-amyloid risk–benefit tradeoffs, and coordinating multidisciplinary stakeholders ...

Whether you have any of the symptoms or not, there are things you can do to reduce your dementia risk.

We can control, or at least positively influence, the risk factors associated with the development of nearly half of all dementias, says a new study from Skåne University Hospital in Sweden.